Carlos Miguel Costa Alves
机构: University of Coimbra, Faculty of Pharmacy
每年引用次数
引用次数
引用: 1,616
H-指数: 20
I10-指数 : 29
出版物: 150
A systematic review of the methodological quality of economic studies evaluating ophthalmic drugs
Inês Souto Ribeiro , Francisco Jorge Batel Marques , Dalila Gil Alves , Carlos Miguel Costa Alves
Expert Review of Pharmacoeconomics & Outcomes Research 19 ( 4) 421 -430
2
2019
The role of Meta-analysis in Pharmacovigilance: how best to combine different sources of evidence about harms?
Carlos Miguel Costa Alves
Universidade de Coimbra (Portugal)
2
2014
SEGURANÇA DOS MEDICAMENTOS BIOLÓGICOS OFTÁLMICOS: REVISÃO SISTEMÁTICA
Ana Penedones , Francisco Batel Marques , Carlos Alves , Diogo Mendes
Revista Portuguesa de Farmacoterapia 7 ( 1) 25 -41
2015
ACUTE PANCREATITIS ASSOCIATED WITH EXENATIDE AND LIRAGLUTIDE: A META-ANALYSIS
Francisco Batel-Marques , Carlos Alves , Ana Filipa Macedo
Revista Portuguesa de Farmacoterapia 4 ( 3) 28 -38
2012
I Encontro da Rede Sudeste de Repositórios Institucionais: sessão Pecha Kucha
Éder de Almeida Freyre , Angelo José Moreira Silva , Claudete Fernandes de Queiroz , Raphael Belchior Rodrigues
Fiocruz/UFRJ
2019
Segurança de Antidiabéticos Orais: Análise de Desproporcionalidade no Sistema Português de Farmacovigilância
Carlos Alves , Diogo Mendes , Francisco Batel Marques
Revista Portuguesa de Farmacoterapia 11 20 -30
2019
Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses
Francisco Batel-Marques , Ana Penedones , Carlos Alves , Diogo Mendes
BMJ Open 10 ( 12)
2020
The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis
Ana Penedones , Francisco Batel Marques , Carlos Alves , Diogo Mendes
Jcr-journal of Clinical Rheumatology
11
2021
Number needed to harm in the post‐marketing safety evaluation: results for rosiglitazone and pioglitazone
Diogo Mendes , Carlos Alves , Francisco Batel-Marques
Pharmacoepidemiology and Drug Safety 24 ( 12) 1259 -1270
16
2015
Data sources on drug safety evaluation: a review of recent published meta‐analyses
Carlos Alves , Francisco Batel-Marques , Ana Filipa Macedo
Pharmacoepidemiology and Drug Safety 21 ( 1) 21 -33
43
2012
A systematic review of observational studies evaluating costs of adverse drug reactions
Francisco Batel-Marques , Ana Penedones , Diogo Mendes , Carlos Alves
ClinicoEconomics and Outcomes Research 8 413 -426
22
2016
Prevalence of Undiagnosed Hypothyroidism in Europe: A Systematic Review and Meta-Analysis
Diogo Mendes , Carlos Alves , Nuno Silverio , Francisco Batel Marques
European thyroid journal 8 ( 3) 130 -143
8
2019
Spontaneous reports of hypersensitivity adverse drug reactions in Portugal: a retrospective analysis
Diogo Mendes , Ana Rita Oliveira , Carlos Alves , Francisco Batel Marques
Expert Opinion on Drug Safety 19 ( 6) 763 -769
2020
Testing the usefulness of the number needed to treat to be harmed (NNTH) in benefit-risk evaluations: case study with medicines withdrawn from the European market due to safety reasons.
Diogo Mendes , Carlos Alves , Francisco Batel Marques
Expert Opinion on Drug Safety 15 ( 10) 1301 -1312
11
2016
Number needed to treat (NNT) in clinical literature: an appraisal
Diogo Mendes , Carlos Alves , Francisco Batel-Marques
BMC Medicine 15 ( 1) 112 -112
48
2017
Recommendations to conduct and report systematic reviews in medical literature: a scoping review.
Ana Penedones , Carlos Alves , Francisco Batel-Marques
BMC Medical Research Methodology 19 ( 1) 1 -14
2019
The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review.
Patrícia Dias , Ana Penedones , Carlos Alves , Carlos Ribeiro
Current Drug Safety 10 ( 3) 234 -250
23
2015
Statins and risk of cataracts: A systematic review and meta-analysis of observational studies.
Carlos Alves , Diogo Mendes , Francisco Batel Marques
Cardiovascular Therapeutics 36 ( 6)
5
2018
Intensive safety monitoring program of antineoplastic medicines: A pilot study in a Portuguese oncology hospital.
Diogo Mendes , Graça Rigueiro , Rui S Silva , Ana Penedones
Journal of Oncology Pharmacy Practice 26 ( 1) 133 -140
1
2020
Sources of information used by regulatory agencies on the generation of drug safety alerts.
Carlos Alves , Ana Filipa Macedo , Francisco Batel Marques
European Journal of Clinical Pharmacology 69 ( 12) 2083 -2094
19
2013